| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| HURNHuron Consulting Group Inc. | 3.2B | 185.58 | 29.60 | 9.11% | 6.66% | 21.68% | 6.02% | 0.71 |
| SBCSBC Medical Group Holdings Incorporated | 462.62M | 4.51 | 9.34 | 6.13% | 24.28% | 17.47% | 3.71% | 0.06 |
| SBCWWSBC Medical Group Holdings Incorporated | 0.25 | 0.52 | 6.13% | 24.28% | 17.47% | 0.06 | ||
| RYOJrYojbaba Co., Ltd. Common Shares | 37.46M | 3.33 | 5.6% | 11.51% | 68.18% | 1.82% | 4.12 |
| Dec 2023 | Dec 2024 | |
|---|---|---|
| Sales/Revenue | 10.96M | 11.58M |
| Revenue Growth % | - | 0.06% |
| Cost of Goods Sold | 7.25M | 7.12M |
| COGS % of Revenue | 0.66% | 0.61% |
| Gross Profit | 3.72M | 4.46M |
| Gross Margin % | 0.34% | 0.39% |
| Gross Profit Growth % | - | 0.2% |
| Operating Expenses | 2.41M | 2.6M |
| OpEx % of Revenue | 0.22% | 0.22% |
| Selling, General & Admin | 2.37M | 2.58M |
| SG&A % of Revenue | 0.22% | 0.22% |
| Research & Development | 0 | 0 |
| R&D % of Revenue | - | - |
| Other Operating Expenses | 39.32K | 20.01K |
| Operating Income | 1.31M | 1.86M |
| Operating Margin % | 0.12% | 0.16% |
| Operating Income Growth % | - | 0.43% |
| EBITDA | 1.64M | 2.33M |
| EBITDA Margin % | 0.15% | 0.2% |
| EBITDA Growth % | - | 0.42% |
| D&A (Non-Cash Add-back) | 333.58K | 469.3K |
| EBIT | 1.48M | 2.02M |
| Net Interest Income | -80.17K | -76.95K |
| Interest Income | 12.76K | 322 |
| Interest Expense | 92.93K | 77.27K |
| Other Income/Expense | 81.72K | 82.49K |
| Pretax Income | 1.39M | 1.94M |
| Pretax Margin % | 0.13% | 0.17% |
| Income Tax | 616.35K | 611.02K |
| Effective Tax Rate % | 0.56% | 0.69% |
| Net Income | 770.57K | 1.33M |
| Net Margin % | 0.07% | 0.12% |
| Net Income Growth % | - | 0.73% |
| Net Income (Continuing) | 770.57K | 1.33M |
| Discontinued Operations | 0 | 0 |
| Minority Interest | 0 | 0 |
| EPS (Diluted) | 0.07 | 0.00 |
| EPS Growth % | - | -1% |
| EPS (Basic) | 0.07 | 0.00 |
| Diluted Shares Outstanding | 11.25M | 0 |
| Basic Shares Outstanding | 11.25M | 0 |
| Dividend Payout Ratio | - | - |
| Dec 2023 | Dec 2024 | |
|---|---|---|
| Total Current Assets | 6.64M | 6.47M |
| Cash & Short-Term Investments | 4.78M | 2.61M |
| Cash Only | 4.78M | 2.61M |
| Short-Term Investments | 0 | 0 |
| Accounts Receivable | 1.07M | 2.77M |
| Days Sales Outstanding | 35.57 | 87.32 |
| Inventory | 95.28K | 66K |
| Days Inventory Outstanding | 4.8 | 3.38 |
| Other Current Assets | 697.85K | 1.03M |
| Total Non-Current Assets | 11.36M | 9.58M |
| Property, Plant & Equipment | 7.94M | 6.77M |
| Fixed Asset Turnover | 1.38x | 1.71x |
| Goodwill | 0 | 0 |
| Intangible Assets | 2.09M | 1.66M |
| Long-Term Investments | 0 | 0 |
| Other Non-Current Assets | 364.75K | 296.13K |
| Total Assets | 18M | 16.06M |
| Asset Turnover | 0.61x | 0.72x |
| Asset Growth % | - | -0.11% |
| Total Current Liabilities | 4.73M | 4.57M |
| Accounts Payable | 673.37K | 1.19M |
| Days Payables Outstanding | 33.91 | 61.01 |
| Short-Term Debt | 2.09M | 1.27M |
| Deferred Revenue (Current) | 390.38K | 256.91K |
| Other Current Liabilities | 94.27K | 187.75K |
| Current Ratio | 1.40x | 1.42x |
| Quick Ratio | 1.38x | 1.40x |
| Cash Conversion Cycle | 6.46 | 29.7 |
| Total Non-Current Liabilities | 11.89M | 8.97M |
| Long-Term Debt | 5.63M | 3.77M |
| Capital Lease Obligations | 5.63M | 4.63M |
| Deferred Tax Liabilities | 0 | 0 |
| Other Non-Current Liabilities | 633.25K | 563.98K |
| Total Liabilities | 16.61M | 13.54M |
| Total Debt | 14.34M | 10.39M |
| Net Debt | 9.56M | 7.78M |
| Debt / Equity | 10.34x | 4.12x |
| Debt / EBITDA | 8.75x | 4.46x |
| Net Debt / EBITDA | 5.84x | 3.34x |
| Interest Coverage | 14.04x | 24.08x |
| Total Equity | 1.39M | 2.52M |
| Equity Growth % | - | 0.82% |
| Book Value per Share | 0.12 | - |
| Total Shareholders' Equity | 1.39M | 2.52M |
| Common Stock | 41.55K | 41.55K |
| Retained Earnings | 295.2K | 1.63M |
| Treasury Stock | 0 | 0 |
| Accumulated OCI | -299.83K | -497.84K |
| Minority Interest | 0 | 0 |
| Dec 2023 | Dec 2024 | |
|---|---|---|
| Cash from Operations | 388.99K | 802.39K |
| Operating CF Margin % | 0.04% | 0.07% |
| Operating CF Growth % | - | 1.06% |
| Net Income | 770.57K | 1.33M |
| Depreciation & Amortization | 333.58K | 469.3K |
| Stock-Based Compensation | 0 | 0 |
| Deferred Taxes | 224.86K | 5.32K |
| Other Non-Cash Items | 1.29M | 712.11K |
| Working Capital Changes | -2.23M | -1.72M |
| Change in Receivables | 184.47K | -1.89M |
| Change in Inventory | -96.06K | 20.26K |
| Change in Payables | -421.85K | 1.05M |
| Cash from Investing | 625.61K | -121.24K |
| Capital Expenditures | -70.34K | -121.24K |
| CapEx % of Revenue | 0.01% | 0.01% |
| Acquisitions | - | - |
| Investments | - | - |
| Other Investing | 695.96K | 0 |
| Cash from Financing | -1.32M | -2.43M |
| Debt Issued (Net) | - | - |
| Equity Issued (Net) | - | - |
| Dividends Paid | 0 | 0 |
| Share Repurchases | - | - |
| Other Financing | -615.49K | -411.24K |
| Net Change in Cash | - | - |
| Free Cash Flow | -1.42M | 681.14K |
| FCF Margin % | -0.13% | 0.06% |
| FCF Growth % | - | 1.48% |
| FCF per Share | -0.13 | - |
| FCF Conversion (FCF/Net Income) | 0.50x | 0.60x |
| Interest Paid | 92.93K | 77.27K |
| Taxes Paid | 321.2K | 297.85K |
| Metric | 2023 | 2024 |
|---|---|---|
| Return on Equity (ROE) | 55.56% | 68.18% |
| Return on Invested Capital (ROIC) | 8.94% | 13.13% |
| Gross Margin | 33.89% | 38.5% |
| Net Margin | 7.03% | 11.51% |
| Debt / Equity | 10.34x | 4.12x |
| Interest Coverage | 14.04x | 24.08x |
| FCF Conversion | 0.50x | 0.60x |
| Revenue Growth | - | 5.6% |
rYojbaba Co., Ltd. Common Shares (RYOJ) reported $11.6M in revenue for fiscal year 2024. This represents a 6% increase from $11.0M in 2023.
rYojbaba Co., Ltd. Common Shares (RYOJ) grew revenue by 5.6% over the past year. This is steady growth.
Yes, rYojbaba Co., Ltd. Common Shares (RYOJ) is profitable, generating $1.3M in net income for fiscal year 2024 (11.5% net margin).
rYojbaba Co., Ltd. Common Shares (RYOJ) has a return on equity (ROE) of 68.2%. This is excellent, indicating efficient use of shareholder capital.
rYojbaba Co., Ltd. Common Shares (RYOJ) generated $0.7M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.